These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 4611028)
1. [Heparin--its physiological action and use in the treatment of certain diseases]. Burbanov G Vutr Boles; 1974; 13(1):1-13. PubMed ID: 4611028 [No Abstract] [Full Text] [Related]
2. [Heparin, its function and clinical use]. Donner L Vnitr Lek; 1979 Feb; 25(2):171-7. PubMed ID: 425349 [No Abstract] [Full Text] [Related]
3. [Principles, limits, and modalities of application of classical anticoagulants]. Vergoz D Phlebologie; 1973; 26(1):105-7. PubMed ID: 4724444 [No Abstract] [Full Text] [Related]
4. [Principles of the treatment of hypercoagulabilities with a rational anticoagulant therapy]. Raby C Presse Med (1893); 1969 Jan; 77(1):17-9. PubMed ID: 5785756 [No Abstract] [Full Text] [Related]
5. [Prevention of thrombophilic states by prolonged activation of fibrinolysis]. De Nicola P Rev Atheroscler (Paris); 1967; 9(3):20-2. PubMed ID: 4174225 [No Abstract] [Full Text] [Related]
7. [Notes on the more effective fibrinolytic effect of nicotinic acid in an extemporaneous drug association]. Ferliga G G Gerontol; 1967 Jun; 15(6):737-42. PubMed ID: 5604105 [No Abstract] [Full Text] [Related]
8. [The influence of heparin on the acute consumption coagulopathy and the subsequent hypercoagulability of the blood. A study by animal experiment]. Vinazzer H Thromb Diath Haemorrh; 1968 Mar; 19(1):255-66. PubMed ID: 5652233 [No Abstract] [Full Text] [Related]
9. [Studies on plasma hypercoagulability. 1. Heparin resistance in various diseases and its relation to coagulation factors, anticoagulant therapy, platelet and heparin co-factor]. Satake K Naika Hokan; 1969 Apr; 16(4):127-38. PubMed ID: 5816626 [No Abstract] [Full Text] [Related]
10. Heparin. Jaques LB New Istanbul Contrib Clin Sci; 1973 Oct; 10(4):208-21. PubMed ID: 4132870 [No Abstract] [Full Text] [Related]
11. [Effect of heparin antagonists on its ability to form gels in tissue homogenates]. Sergeev PV; Seĭfulla RD Farmakol Toksikol; 1969; 32(6):718-9. PubMed ID: 5381604 [No Abstract] [Full Text] [Related]
12. [Experiences with Calciparin, a new subcutaneously injectable heparin preparation]. Sessner HH; Brockhaus W; Kunzmann G; Stingl J Med Welt; 1971 Jan; 5():187-91. PubMed ID: 5546024 [No Abstract] [Full Text] [Related]
13. [Thrombosis and heart infarct prevention using subcutaneous heparin therapy]. Steger W Fortschr Med; 1974 Jan; 92(2):76-9. PubMed ID: 4818252 [No Abstract] [Full Text] [Related]
14. [Medium and long period treatment with heparin]. Raynaud R; Brochier M Angeiologie; 1967; 19(5):7-9. PubMed ID: 5621976 [No Abstract] [Full Text] [Related]
15. In vitro and in vivo effects of heparin on cryofibrinogen. Komp DM; Donaldson MH N Engl J Med; 1968 Dec; 279(26):1439-40. PubMed ID: 5722919 [No Abstract] [Full Text] [Related]
16. [Low dosage of heparin. Theoretical and practical evaluation]. Gormsen J; Feddersen C; Clausen NT Ugeskr Laeger; 1974 Apr; 136(16):865-70. PubMed ID: 4825561 [No Abstract] [Full Text] [Related]
17. [Data on thrombophilic states]. Raffaello B; Bruno B Haematol Lat; 1969; 12(3):569-94. PubMed ID: 4919424 [No Abstract] [Full Text] [Related]
18. [Heparin: its mechanism of action and use in cardiology]. Serneri GG; Rostagno C G Ital Cardiol; 1990 Jul; 20(7):670-4. PubMed ID: 2245907 [No Abstract] [Full Text] [Related]
19. [Prolonged anti-coagulating treatment with sub-cutaneous heparine. Experience at the Centre de Réanimation of the Hôpital Claude-Bernard]. Amstutz P Angeiologie; 1967; 19(5):11-7. PubMed ID: 4193818 [No Abstract] [Full Text] [Related]
20. Thrombosis and coagulation: operative management of the anticoagulated patient. Owens CD; Belkin M Surg Clin North Am; 2005 Dec; 85(6):1179-89, x. PubMed ID: 16326201 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]